EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extracellular nicotinamide phosphoribosyltransferase visfatin activates JAK2-STAT3 pathway in cancer-associated fibroblasts to promote colorectal cancer metastasis

Yun Lei, Dan Shu, Jianyu Xia, Tao Zhang iD, He Wei

Genes & Genomics · 2025

DOI: 10.1007/s13258-024-01596-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes & Genomics, 2025. Verfasst von Yun Lei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pathological Diagnosis Center, Zhoushan Hospital of Zhejiang Province, Zhejiang, China. Hauptthemen laut MEDLINE: Nicotinamide Phosphoribosyltransferase, Colorectal Neoplasms, STAT3 Transcription Factor, Janus Kinase 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metastasis is one of the major challenges in the treatment of colorectal cancer (CRC), during which cancer-associated fibroblasts (CAFs) in the tumor microenvironment are critically involved.

Objective

In this study, we aim to explore the regulatory role of extracellular nicotinamide phosphoribosyltransferase Visfatin and its impact on CRC metastasis.

Methods

To examine the effect of visfatin on CAFs, human CRC tissue-derived CAFs were exposed to visfatin, and the expression of inflammatory factors, activation of JAK-STAT pathway and production of ROS in CAFs were assessed. To examine the effect of visfatin-treated CAFs on CRC metastasis, human CRC cell line SW480 or SW620 were cultured with the conditioned medium derived from visfatin-treated CAFs, and the invasion and migration ability of SW480 or SW620 cells were evaluated by transwell migration and matrigel invasion assays.

Results

Our previous study found that visfatin, a secreted form of nicotinamide phosphoribosyltransferase that governs the rate-limiting step of NAD synthesis, promoted CRC metastasis. However, little is known about the effect of visfatin on CAFs. The conditioned medium derived from visfatin- treated CAFs promotes the migratory and invasive capability of CRC cells, and enhance lung metastasis in mouse model. Visfatin treatment stimulated the expression of a couple of inflammatory factors in CAFs, which was mediated by visfatin-induced activation of JAK- STAT pathway and accumulation of ROS. Inhibition of JAK-STAT pathway or neutralization of cellular ROS attenuated visfatin-mediated migration and invasion of CRC cells.

Conclusions

The present work highlights a critical role of visfatin in the crosstalk between CRC cells and CAFs, which moonlight as a non-metabolic extracellular signal molecule to hijacks JAK-STAT pathway in CAFs to promote CRC metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nicotinamide PhosphoribosyltransferaseColorectal NeoplasmsSTAT3 Transcription FactorJanus Kinase 2Cancer-Associated FibroblastsCytokinesHumansAnimalsMiceCell Line, TumorSignal TransductionCell MovementNeoplasm MetastasisReactive Oxygen SpeciesTumor MicroenvironmentMice, NudeCulture Media, Conditioned

Stichwörter der Autor:innen

Cancer therapyCancer-associated fibroblastsColorectal cancerMetabolismVisfatin

Substanzen

Nicotinamide PhosphoribosyltransferaseSTAT3 Transcription FactorJanus Kinase 2STAT3 protein, humanJAK2 protein, humannicotinamide phosphoribosyltransferase, humanCytokinesReactive Oxygen SpeciesCulture Media, Conditioned

Autor:innen und Institutionen

  • Pathological Diagnosis Center, Zhoushan Hospital of Zhejiang Province, Zhejiang, China.
  • School of Bioscience and Technology, Chengdu Medical College, Chengdu, China.
  • School of Basic Medical Science, Chengdu Medical College, Chengdu, China.
  • School of Bioscience and Technology, Chengdu Medical College, Chengdu, China. ztbill@cmc.edu.cn.
  • The Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, China. ztbill@cmc.edu.cn.
  • School of Bioscience and Technology, Chengdu Medical College, Chengdu, China. weihe@cmc.edu.cn.

ORCID-Profile: Tao Zhang

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Department of Sichuan Province

Zitieren

APA

Lei, Y., Shu, D., Xia, J., Zhang, T., & Wei, H. (2025). Extracellular nicotinamide phosphoribosyltransferase visfatin activates JAK2-STAT3 pathway in cancer-associated fibroblasts to promote colorectal cancer metastasis. Genes & Genomics. https://doi.org/10.1007/s13258-024-01596-6

Vancouver

Lei Y, Shu D, Xia J, Zhang T, Wei H. Extracellular nicotinamide phosphoribosyltransferase visfatin activates JAK2-STAT3 pathway in cancer-associated fibroblasts to promote colorectal cancer metastasis. Genes & Genomics. 2025. doi:10.1007/s13258-024-01596-6

BibTeX
@article{Lei2025,
  author = {Lei, Yun and Shu, Dan and Xia, Jianyu and Zhang, Tao and Wei, He},
  title = {Extracellular nicotinamide phosphoribosyltransferase visfatin activates JAK2-STAT3 pathway in cancer-associated fibroblasts to promote colorectal cancer metastasis},
  journal = {Genes & Genomics},
  year = {2025},
  doi = {10.1007/s13258-024-01596-6}
}
Kostenlos starten →